» Articles » PMID: 29257070

Recent Advances in Cancer Therapy Based on Dual Mode Gold Nanoparticles

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2017 Dec 20
PMID 29257070
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Many tumor-targeted strategies have been used worldwide to limit the side effects and improve the effectiveness of therapies, such as chemotherapy, radiotherapy (RT), etc. Biophotonic therapy modalities comprise very promising alternative techniques for cancer treatment with minimal invasiveness and side-effects. These modalities use light e.g., laser irradiation in an extracorporeal or intravenous mode to activate photosensitizer agents with selectivity in the target tissue. Photothermal therapy (PTT) is a minimally invasive technique for cancer treatment which uses laser-activated photoabsorbers to convert photon energy into heat sufficient to induce cells destruction via apoptosis, necroptosis and/or necrosis. During the last decade, PTT has attracted an increased interest since the therapy can be combined with customized functionalized nanoparticles (NPs). Recent advances in nanotechnology have given rise to generation of various types of NPs, like gold NPs (AuNPs), designed to act both as radiosensitizers and photothermal sensitizing agents due to their unique optical and electrical properties i.e., functioning in dual mode. Functionalized AuNPS can be employed in combination with non-ionizing and ionizing radiation to significantly improve the efficacy of cancer treatment while at the same time sparing normal tissues. Here, we first provide an overview of the use of NPs for cancer therapy. Then we review many recent advances on the use of gold NPs in PTT, RT and PTT/RT based on different types of AuNPs, irradiation conditions and protocols. We refer to the interaction mechanisms of AuNPs with cancer cells via the effects of non-ionizing and ionizing radiations and we provide recent existing experimental data as a baseline for the design of optimized protocols in PTT, RT and PTT/RT combined treatment.

Citing Articles

Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.

Rahman M, Jalouli M, Yadab M, Al-Zharani M Cancers (Basel). 2025; 17(4).

PMID: 40002294 PMC: 11852615. DOI: 10.3390/cancers17040701.


Nanoparticle-Mediated Radiotherapy: Unraveling Dose Enhancement and Apoptotic Responses in Cancer and Normal Cell Lines.

Kouri M, Spyratou E, Kalkou M, Patatoukas G, Angelopoulou E, Tremi I Biomolecules. 2023; 13(12).

PMID: 38136591 PMC: 10742116. DOI: 10.3390/biom13121720.


Plasmonic porous micro- and nano-materials based on Au/Ag nanostructures developed for photothermal cancer therapy: challenges in clinicalization.

Taheri-Ledari R, Ganjali F, Zarei-Shokat S, Dinmohammadi R, Asl F, Emami A Nanoscale Adv. 2023; 5(24):6768-6786.

PMID: 38059020 PMC: 10696950. DOI: 10.1039/d3na00763d.


Cancer Treatment Using Different Shapes of Gold-Based Nanomaterials in Combination with Conventional Physical Techniques.

Tarantino S, Caricato A, Rinaldi R, Capomolla C, De Matteis V Pharmaceutics. 2023; 15(2).

PMID: 36839822 PMC: 9968101. DOI: 10.3390/pharmaceutics15020500.


Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review.

Ojha A, Jaiswal S, Bharti P, Mishra S Cancers (Basel). 2023; 15(1).

PMID: 36612158 PMC: 9817889. DOI: 10.3390/cancers15010162.


References
1.
Shao J, Griffin R, Galanzha E, Kim J, Koonce N, Webber J . Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics. Sci Rep. 2013; 3:1293. PMC: 3582999. DOI: 10.1038/srep01293. View

2.
Butterworth K, McMahon S, Currell F, Prise K . Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale. 2012; 4(16):4830-8. DOI: 10.1039/c2nr31227a. View

3.
Yao X, Huang C, Chen X, Yi Z, Sanche L . Chemical Radiosensitivity of DNA Induced by Gold Nanoparticles. J Biomed Nanotechnol. 2015; 11(3):478-85. DOI: 10.1166/jbn.2015.1922. View

4.
Cherukuri P, Glazer E, Curley S . Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev. 2009; 62(3):339-45. PMC: 2827640. DOI: 10.1016/j.addr.2009.11.006. View

5.
Dimitriou N, Tsekenis G, Balanikas E, Pavlopoulou A, Mitsiogianni M, Mantso T . Gold nanoparticles, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol Ther. 2017; 178:1-17. DOI: 10.1016/j.pharmthera.2017.03.006. View